| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9744 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.7007 |
| P-glycoprotein Substrate | Non-substrate | 0.7370 |
| P-glycoprotein Inhibitor | Inhibitor | 0.5931 |
| Non-inhibitor | 0.9205 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7480 |
| Distribution |
| Subcellular localization | Lysosome | 0.8043 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8230 |
| CYP450 2D6 Substrate | Non-substrate | 0.5067 |
| CYP450 3A4 Substrate | Non-substrate | 0.5382 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9380 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7532 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7129 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.6901 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7285 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6944 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9390 |
| Inhibitor | 0.5502 |
| AMES Toxicity | Non AMES toxic | 0.5146 |
| Carcinogens | Non-carcinogens | 0.7541 |
| Fish Toxicity | High FHMT | 0.9813 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9884 |
| Honey Bee Toxicity | Low HBT | 0.6819 |
| Biodegradation | Not ready biodegradable | 0.9208 |
| Acute Oral Toxicity | III | 0.6722 |
| Carcinogenicity (Three-class) | Non-required | 0.7562 |